Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity

BJU Int. 2005 Sep;96(4):629-33. doi: 10.1111/j.1464-410X.2005.05697.x.

Abstract

Objective: To assess the importance of normalizing bladder capacity to the age-expected capacity in children with refractory monosymptomatic nocturnal enuresis (MNE), and to evaluate the long-term results when these children grow into adolescence.

Patients and methods: The study included 34 children with refractory MNE; all were treated > 5 years earlier for their MNE using a combined stepwise approach, consisting of retention control training, oxybutynin and an enuresis alarm. Data were obtained on their enuretic state, night-time voiding behaviour and bladder capacity, from a questionnaire and a voiding chart.

Results: Before starting treatment, all patients had a bladder capacity that was too small for their age. After the combined stepwise approach, MNE improved in all patients and 24 (71%) were cured. Although the bladder capacity was increased to the age-expected capacity in 26 (76%), most woke at night to void. Currently, at a mean of 7.7 years after the primary treatment, 28 (82%) of the patients are completely dry at night, of whom 15 (54%) arouse to void for 35% of the nights. Six patients (18%) still have some enuretic episodes. Only those who were dry after primary treatment and remained dry had a normal age-expected increase in bladder capacity. For all others there was a decrease in age-related bladder capacity.

Conclusions: In patients with refractory MNE, a combined stepwise approach improves and may even eliminate enuresis, but normal night-time bladder behaviour in adolescence and adulthood is only achieved in some. Furthermore, about a fifth still have some enuretic episodes.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Biofeedback, Psychology
  • Child
  • Child, Preschool
  • Cholinergic Antagonists / therapeutic use
  • Combined Modality Therapy
  • Enuresis / drug therapy
  • Enuresis / pathology*
  • Enuresis / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Mandelic Acids / therapeutic use
  • Physical Therapy Modalities*
  • Prospective Studies
  • Treatment Outcome
  • Urinary Bladder / pathology*
  • Urination

Substances

  • Cholinergic Antagonists
  • Mandelic Acids
  • oxybutynin